Annovis Bio Inc
(ANVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,087 | -1,067 | -56,204 | -33,991 | -19,274 |
| Accounts payable and accrued liabilities | 2,102 | 2,814 | -2,668 | -2,035 | -2,788 |
| Other Working Capital | 3,183 | 368 | -229 | -357 | -5,072 |
| Other Operating Activity | -9,605 | -9,148 | 19,134 | 5,781 | 5,902 |
| Operating Cash Flow | $-10,408 | $-7,033 | $-39,967 | $-30,602 | $-21,233 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,651 | 4,415 | 17,344 | 8,580 | 8,580 |
| Financing Cash Flow | $8,651 | $4,415 | $17,344 | $8,580 | $8,580 |
| Beginning Cash Position | 5,755 | 5,755 | 28,378 | 28,378 | 28,378 |
| End Cash Position | 3,998 | 3,137 | 5,755 | 6,355 | 15,725 |
| Net Cash Flow | $-1,757 | $-2,618 | $-22,623 | $-22,023 | $-12,653 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,408 | -7,033 | -39,967 | -30,602 | -21,233 |
| Free Cash Flow | -10,408 | -7,033 | -39,967 | -30,602 | -21,233 |